Serum NLRP3 and S1P as Potential Diagnostic and Prognostic Biomarkers in Female Metastatic and Non-Metastatic Breast Cancer Patients
Background: Breast cancer (BC) is considered the main cause of death in women worldwide. Overexpression of Sphingosine 1-phosphate (S1P) receptors in estrogen receptor (ER) negative BC patients is linked to poor prognosis. In vitro, the bioactive lipid metabolite S1P induced Nod-like receptor3 (NLRP...
Saved in:
| Main Authors: | Anas R. Soltan, Amany M. Kamal, Reham A. A. El-Shimy, Hala O. El-Mesallamy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ain Shams University
2023-12-01
|
| Series: | Archives of Pharmaceutical Sciences Ain Shams University |
| Subjects: | |
| Online Access: | https://aps.journals.ekb.eg/article_329478.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NLRP11 is required for canonical NLRP3 and non-canonical inflammasome activation during human macrophage infection with mycobacteria
by: Mateusz Szczerba, et al.
Published: (2025-05-01) -
The NLRP1 Emerges as a Promising Therapeutic Target and Prognostic Biomarker Across Multiple Cancer Types: A Comprehensive Pan‐Cancer Analysis
by: Leila Habibipour, et al.
Published: (2025-04-01) -
MCM4 as Potential Metastatic Biomarker in Lung Adenocarcinoma
by: Hung-Chih Lai, et al.
Published: (2025-06-01) -
Case Report: A heterozygous mutation of NLRP3 in a Chinese child with NLRP3-AID
by: Yangming Ruan, et al.
Published: (2025-08-01) -
Metastatic Osteosarcoma of Lacrimal Gland
by: Smitha K Shambhu, et al.
Published: (2017-07-01)